Sugi Predict

Sugi Predict / Compounds / SCHEMBL23102166

SCHEMBL23102166

SCHEMBL23102166

CN(C)c1ccc(S(=O)(=O)N2CCCN(CC3CCCCC3)CCCN(S(=O)(=O)N3CCC(C)(C)CC3)CC3(CC3)C2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ OPRM1 P35372 2/20 0.38
▸ XBP1 P17861 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ NR3C1 P04150 2/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ LMNA P02545 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ CYP3A4 P08684 6/20 0.36
▸ CYP1A2 P05177 5/20 0.36
▸ CYP2D6 P10635 5/20 0.36
▸ USP2 O75604 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HSD11B1 P28845 1/20 0.34
▸ OPRL1 P41146 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23102163 0.94 TSHR (0.44) TSHRMEN1KMT2AOPRM1XBP1
SCHEMBL23102233 0.94 TSHR (0.44) TSHRMEN1KMT2AOPRM1XBP1
SCHEMBL21361559 0.94 TSHR (0.44) TSHRMEN1KMT2AOPRM1XBP1
Hydrochloric Acid SCHEMBL21359222 0.94 TSHR (0.43) TSHRMEN1KMT2AOPRM1XBP1
SCHEMBL23102243 0.91 KMT2A (0.43) TSHRMEN1KMT2AOPRM1XBP1
SCHEMBL23102111 0.90 HSD11B1 (0.39) TSHRMEN1KMT2AOPRM1XBP1
SCHEMBL24755202 0.90 LMNA (0.42) TSHRMEN1KMT2ANR3C1ALDH1A1
SCHEMBL23102121 0.89 HSD11B1 (0.41) TSHRMEN1KMT2AOPRM1XBP1
SCHEMBL23102161 0.88 ALDH1A1 (0.43) TSHRMEN1KMT2AOPRM1XBP1
SCHEMBL23102239 0.88 NPSR1 (0.44) TSHRMEN1KMT2AOPRM1XBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3765447-B1 TRIAZACYCLODODECANSULFONAMIDE (\"TCD\")-BASED PROTEIN SECRETION INHIBITORS KEZAR LIFE SCIENCES (US) 2023-07-12 — — EP disclosed
EP-3765447-B1 TRIAZACYCLODODECANSULFONAMIDE (\"TCD\")-BASED PROTEIN SECRETION INHIBITORS KEZAR LIFE SCIENCES (US) 2023-07-12 — — EP disclosed
US-11578055-B2 Triazacyclododecansulfonamide (“TCD”)-based protein secretion inhibitors KEZAR LIFE SCIENCES (US) 2023-02-14 — — US disclosed
US-20220402891-A1 TRIAZACYCLODODECANSULFONAMIDE (TCD)-BASED PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-12-22 — — US disclosed
US-20210078974-A1 TRIAZACYCLODODECANSULFONAMIDE (\"TCD\")-BASED PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578055-B2 Triazacyclododecansulfonamide (“TCD”)-based protein secretion inhibitors SEC61B, SEC61A1, SEC61G TSHR 727/4885MEN1 2214/4885KMT2A 4856/4885
US-20220402891-A1 TRIAZACYCLODODECANSULFONAMIDE (TCD)-BASED PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G TSHR 976/4885MEN1 2318/4885KMT2A 4863/4885
US-20210078974-A1 TRIAZACYCLODODECANSULFONAMIDE (\"TCD\")-BASED PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G TSHR 616/4885MEN1 2274/4885KMT2A 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.